13188-55-1

Basic information

• Product Name: 1,4-Benzenedicarboxylic acid, monomethyl ester, hydrazide
• CAS NO: 13188-55-1
• Molecular Formula: C9H10N2O3
• Molecular Weight: 194.19
• Mol File: 13188-55-1.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: 1,4-Benzenedicarboxylic acid, monomethyl ester, hydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-Benzenedicarboxylic acid, monomethyl ester, hydrazide(13188-55-1)
• EPA Substance Registry System: 1,4-Benzenedicarboxylic acid, monomethyl ester, hydrazide(13188-55-1)

Safety Data

• Hazardous Substances Data: 13188-55-1(Hazardous Substances Data)

Upstream product

• 100-21-0 terephthalic acid 
• 108724-76-1 (carbonic acid ethyl ester)-(terephthalic acid methyl ester)-anhydride 
• 1679-64-7 Monomethyl terephthalate 
• 7377-26-6 4-Methoxycarbonylbenzoyl chloride 
• 120-61-6 1,4-benzenedicarboxylic acid dimethyl ester 

Downstream Products

• 24852-49-1 N-(4-methyl-2-thioxo-thiazol-3-yl)-terephthalamic acid methyl ester 
• 1147111-60-1 methyl 4-[5-[(2R)-2-[5-(3-chlorophenyl)-1,2-oxazol-3-yl]pyrrolidin-1-yl]-4-methyl-1,2,4-triazol-3-yl]benzoate 
• 22816-03-1 4-(1,3,4-oxadiazol-2-yl)benzoic acid methyl ester 
• 1609113-38-3 C₂₄H₂₃N₃O₆ 
• 1609112-76-6 C₂₂H₁₇N₃O₅ 
• 1609113-39-4 C₂₄H₂₁N₃O₅ 
• 1338241-43-2 methyl 4-(9H-benzo[f]pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]diazepin-3-yl)benzoate 
• 1338243-47-2 tert-butyl (1-(4-(9H-benzo[f]pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]diazepin-3-yl)benzoyl)piperidin-4-yl)carbamate 
• 1338243-70-1 4-(9H-benzo[f]pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]diazepin-3-yl)benzoic acid 

Relevant articles and documents

Two polymorphic forms of 2,5-bis-(4-methoxycarbonylphenyl)-1,3,4-oxadiazole

The title compound [systematic name: dimethyl 4,4′-(1,3,4-oxadiazole-2,5-diyl)diphenylenedicarboxylate], C18H14N2O5, crystallizes under similar conditions in two different orthorhombic crystalline forms. In both

Discovery of Novel Small-Molecule Inhibitors of NF-κB Signaling with Antiinflammatory and Anticancer Properties

Excessive NF-κB activation contributes to the pathogenesis of numerous diseases. Small-molecule inhibitors of NF-κB signaling have significant therapeutic potential especially in treating inflammatory diseases and cancers. In this study, we performed a ce

Discovery of highly selective and potent monoamine oxidase B inhibitors: Contribution of additional phenyl rings introduced into?2-aryl-1,3,4-oxadiazin-5(6H)-one

Monoamine oxidase B (MAO-B) is a flavin adenine dinucleotide (FAD)-containing enzyme that plays a major role in the oxidative deamination of biogenic amines and neurotransmitters. Inhibiting MAO-B activity is a promising approach in the treatment of neuro